Study Flashcards
Steps to treat hyperemesis gravidarium
- IVF with multivitamins and B vitamins
- antiemetics
- avoidance of PO
- EN if unable to take PO after 24-48 hrs
- PN if EN trial failed
failed EN trial for hyperemesis is
- n/v/d exacerbation
- significant gastric residuals
- tube displacement
- associated with >5% weight loss
Infusion of phosphate should not exceed
7 mmol/hr
can cause thrombophlebitis and metastatic calcium-phosphate deposition with potential of organ dysfunction
most common complication with PN administration
hyperglycemia
cause of hyperglycemia in the stressed patient
increased insulin resistance
increased gluconeogenesis and glycogenolysis
suppressed insulin secretion
glycemic target for critically ill adult
140-180 mg/dL
110-140 in some cases if can be safely achieved
<110 not recommended due to adverse effects of hypoglycemia
components of basal-bolus regimen
o Basal insulin
o Nutritional component prior to meals
o Correctional insulin
Glutamine dipeptides in parenteral solutions improve…
Improve water solubility
Improve stability during heat sterilization
Improve capability for prolonged shelf life
is free glutamine stable in PN
no
is parenteral or enteral glutamine more beneficial
parenteral - enteral is protein bound and difficult to determine exact content
factors associated with PN prescribing errors
o Inadequate knowledge regarding PN therapy
o Certain patient characteristics – ex. age, impaired renal fnx
o Miscalculation of PN dosages
o Specialized PN dosage formulation
o Prescribing nomenclature
how to order PN ingredients
o Amounts/day for adults
o Amounts/kg/day for pediatric and neonatal
o Limits confusion of conversion from amounts/L, % concentration, and volume
High output fistula is
> 500 ml/day
Is PN routine in Chron’s
no
preferred nutrition intervention in acute pancreatitis
EN
When to use PN in burn patients
only if unable to feed enterally
linked with increased mortality
when may an adult cancer patient benefit from PN preoperatively
when severely malnourished and the therapy is to continue 7-10 days postoperatively
PICC
a catherter inserted via peripheral vein whose distal tip lies in the vena cava
o Cephalic or basilic vein is often the insertion site
PICC disadvantages
High rate of malposition
Limited arm mobility
Limited ability to perform daily self-care due to availability of only one hand
PICC advantages
No risk of pneumothorax
Available as double, single, triple lumen
Does not require repeated skin puncture
CDC recommendations regarding PICCs
Do not routinely place to prevent infection
Catheter replacement at scheduled intervals has not shown decrease in catheter related infections
Catheter insertion with guidewire is associated with less discomfort and mechanical complication
• Replacement during bacteremeia should not be done over a guidewire
Remove PICC only if it is suspected or known to be the source of the infection
central line
catheters with the distal tips in either the superior or inferior vena cava
common complication of bedside central line placement
misplacement including pneumothorax
when can you start infusion after central line placement
immediately if placed with fluoroscopy
if not must radiographically confirm first
can you auscultate to confirm central line tip placement
no
Institute for Healthcare Improvement central line bundle
Group of evidence-based interventions that results in better outcomes when implemented together
Recommends avoiding central venous access devices with high risk for infection, such a femoral catheters, when other access is available
preferred central line site
subclavian
peripheral line osmolarity
up to 900 mOsm/L
osmolarity of 10% dextrose
500
osmolarity of 3% amino acid
300
1 g AA contributes how much osmolarity
10 mOsm
1 g dextrose contributes how much osmolarity
5 mOsm
how does increased amino acid affect calcium phosphate precipitation
reduces risk by forming soluble complexes with calcium reducing free calcium ions available and lowers pH improving calcium phosphate solubility
does CaCl or calcium gluconate dissociate more readily
CaCl
Increased temp affect on dissociation of calcium salts
increases dissociation increasing risk of precipitation
in what order should Ca and Phos be added to reduce risk of precipitate
phos first and ca near end - not back to back
when does calcification occur in pn
serum calcium level multiplied by serum phos level exceeds 55 mg/dl
when are branched chain amino acids indicated in encephalopathy
o Only indicated in chronic encephalopathy for those who cannot tolerate at least 1 gm/kg/day of standard protein despite optimal phamacotherapy
EFAD may be caused by
Failure to provide at least 2-4% of total caloric intake as linoleic acid and 0.25-0.5% as alpha linolenic acid may lead to deficiency
adult lipids to prevent EFAD
500 mL 10% or 250 ml 20% twice weekly
500 ml 20% once weekly
infant lipids for EFAD prevention
05-1 g/kg/day
lab to test for EFAD
triene to tetraene ratio >0.2
EFAD can occur within ___ of exclusive PN without fat emulsion
1-3 weeks
lipid infusion rate in adults
no more than 0.11 gm/kg/hr
lipid infusion rate in children
no more than 0.15 gm/kg/hr
lipid infusion rate in neonates
no more than 0.17 gm/kg/hr
is 10 or 20% lipid emulsion better
20%
allows more efficient triglyceride clearance
10% lipid emulsion is less ideal than 20% because
has increased phospholipid content which is associated with plasma lipid alterations
avoid triglyceride of
>400 in adults
>200 in peds
physical mixture (lipids)
emulsion of two or more oils
structure lipid
created through hydrolysis of triglycerides and transesterification of fatty acids to form composite triglyceride molecule with various propotions of MCFA and LCFA
Advantage over physical mixture because slower rate of release and utilization of MCFA
what should be reduced in hepatobiliary disease PN due to impaired excretion
manganese
copper
aluminum contamination from parenteral nutrition causes
aluminum toxicity
sources of PN aluminum contamination
Calcium and phosphate salts
Heparin
Albumin
o No clear evidence that insulin is source
daily aluminum should not exceed
5 mcg/kg/day
how is manganese excreted
90% via bile into feces
Manganese toxicity
can occur on long term PN
accumulates in brain affecting CNS
monitor manganese by
MRI brain imaging
erythrocyte or whole blood assessment (60-80% in RBCs)
what may increase risk of manganese toxicity
cholestasis and biliary obstruction
early phase of manganese toxicity
weakness
anorexia
headache
apathy
only transfer, measuring, and mixing manipulations with closed or sealed packaging systems performed promptly and attentively
low contamination risk
compounding PN using manual or automated devices with multiple injections, detachments, and attachments of nutrient source products to the device or machine to deliver to final sterile container
medium contamination risk
using nosterile ingreadient or nonsterile devices prior to terminal sterilization
high contamination risk
extemporaneously compounded L-glutamine for supplementation in PN formulation
high contamination risk
cracking - emulsion destabilization
small lipid particles coalesce to form large droplet
signs
• yellow brown oil droplets near TNA surface
• continuous layer of yellow-brown liquid at the surface
• marbling streaking of oil throughout
clinical danger
creaming - emulsion destabilization
occurs almost immediately once IVFE mixed with other chemical constituents
cream layer visible at surface as translucent band separate from remaining dispersion
common, not significant determinant of infusion safety except in extreme cases
PN CHO intake should not exceed
4 mg/kg/min
rapid infusion of phosphate can result in
tetany due to abrupt decrease in serum calcium concentration
metabolic alkalosis can be caused by
- NG suctioning
- volume depletion
- diuretic use
- excess acetate
markers of metabolic alkalosis
increased pH
normal PaCO2
increased serum bicarb
ex of metabolic bone disease
osteomalcia
osteoporosis
osteopenia
aluminum toxicity can cause what (in terms of bone health)
osteomalacia by…
• Impairing calcium bone fixation
• Inhibiting the conversion of vit d
• Reducing PTH secretion
aluminum toxicity is worsened by
renal insufficiency
most important contributor to metabolic bone disease
negative calcium balance
hypocalcemia occurs from
- Decreased calcium intake
* Increased calcium urinary excretion
hypercalcemia occurs from
- Excessive calcium and inadequate phos supplementation
- Excessive protein in PN
- Cyclic PN infusion s
- Chronic metabolic acidosis
protein should not exceed what to help prevent hypercalcemia
o Ideally will not exceed 1.5g/kg/day
what is used to dx metabolic bone disease
bone mineral density
risk factors for metabolic bone disease
chron’s
cancer
short bowel
hyperthryoidism
chron’s contributes to metabolic bone disease because of
Malabsorption of Ca and vit D
Use of corticosteroids
short bowel contributes to metabolic bone disease because of
renal wasting of Ca
PNALD is reduced by
o Cycling PN
o Supplementing with enteral
o Adding ursodiol
o Increasing omega 3:omega 6 ratio
3 basic types of hepatobiliary disorders associated with PN
steatosis
cholestasis
gallbladder sludging/stone
steatosis
• Mild elevation in o Minotransferases o Serum alkalin phosphatase o Bilirubin concentraton o Complication of overfeeding
cholestasis from PN is primarily in
children
cholestasis
- Impaired biliary secrection
- Elevation conjugated bilirubin levels, alkalin phos, gamma glutamyltransferase
- > 2 mg/dL serum conjugated bilirubin is indicator
gallbladder sludging in PN is result of
lack of enteral stimulation
hypertonic hyponatremia
o Hyperglycemia causes shift of water out of cells into EC space, diluting serum sodium
not true sodium or water imbalance
for every 100 mg/dL increase in serum glucose above 100 mg/dL, serum sodium is expected to
decrease by approximately 1.6 mEq/L
causes of hyperglycemia in patient receiving PN
- CHO >4-5 mg/kg/min or 20-25 kcal/kg/day
- stress associated sepsis
- obesity
Develops when fibrin build up inside of vein causes the vascular access device to adhere to the vessel wall
mural thrombus
Layer of fibrin that develops around the outside of a central venous catheter secondary to aggregation of fibrin from the presence of a central venous catheter within a vein
fibrin sheath
fibrin sheath often results in
withdrawal occlusion
fibrin acts as a one-way valve
fibrin sheath is a
thombotic catheter occlusion
fibrin tail
Fibrin build up on the CVC tip
Allows infusion through but prevents withdrawal of blood
intraluminal thrombus
Clot within the catheter lumen
Caused by inadequate flushing and blood reflux
Inability to infuse and aspirate without resistance
pinch off syndrome
Catheter is compressed between first rib and clavicle causing intermittent compression and pinching
pain relived by raising or lowering the arm
pinch off syndrome leads to
- intermittent occlusion of infusion and aspiration
* increased risk of catheter fracture
treatment of pinch off syndrom
removal of catheter and reinsertion at more lateral position in subclavian vein or placement in internal jugular vein
central venous thrombosis
arm, shoulder, or neck swelling, limb, jaw, ear pain, dilated collateral veins over arm, neck, or chest
O.1N hydrochloric acid for clearing
• Crystalline occlusion because its acidic pH is favorable for calcium and phosphate solubility
sodium bicarb for clearing
• Precipitates associated with medication in high pH range such as tobramycin and phenytoin
70% ethanol for clearing
lipid reside
Groshong CVC
Three-position, pressure sensitive valve that restricts blood backflow and air embolism by remain closed when not in use
Groshong CVC eliminate
needs for heparin flushes for patency
should be flushed with NS after med admin or blood aspiration to ensure closed
Systematic approach to prevent unnecessary catheter removals and/or unnecessary instillationsof compounds to relive the catheter occlusion
Obtain thorough hx of signs/symptoms of catheter malfunction from patient
Double-check cather function for patency and blood aspitation
Check for mechanical causes and assess if occlusion nis related to postural changes
• Clamps, kinked tubing, tigh sutures
Obtain thorough hx of recent flushing techniques, medication ninfusion, and blood aspiration
Assess for physical signs of edema, redness, pain, or dilated vessels
refeeding
sodium retension
hypophosphatemia
hypokalemia
hypomagnesemia
Na retention in refeeding leeds to
fluid overload
pulmonary edema
cardia decompensation
hypophosphatemia in refeeding leads to
respiratory failure and seizures
hypokalemia in refeeding leads to
cardiac arrhythmias and neuromuscular effects
hypomagnesemia in refeeding leads to
cardiac arrhythmias and neuromuscular effects
Max PN components
o 30-40 ml/kg/day of fluid
o 7 gm/kg/day CHO
o 2.5 gm/kg/day fat
o 2 gm/kg/day protein
clinical exit site infection
Erythema, tenderness or purulence within 2 cm of catheter exit site
management of clinical exit site infection
- Culture of drainage
- Blood culture
- Topical antimicrobial agent if no purulence and no clinical signs of sepsis
- Systemic antimicrobial if purulenc is present or if topical is unsuccessful
- Removal if systemic fails or patient has clinical signs of sepsis
most common infection for tunneled central venous catheter
contamination of catheter hub
most common infection for nontunneled central venous catheter
extraluminal colonization of catheter or intraluminal colonization of hub and lumen
how to decrease risk of catheter-associated sepsis
Use of full-barrier precutions during catheter insertion
Skin prep with chlorhexidine
Avoid prophylactic use of antibiotic ointment at catheter exit site to not encourage resistant flora growth
No evidence that antibiotic prophylaxis reduces incidence
Do educate health care personelle on how to maintain